0000899243-20-030392.txt : 20201104
0000899243-20-030392.hdr.sgml : 20201104
20201104163919
ACCESSION NUMBER: 0000899243-20-030392
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201102
FILED AS OF DATE: 20201104
DATE AS OF CHANGE: 20201104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mahoney Stephen F.
CENTRAL INDEX KEY: 0001741389
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38541
FILM NUMBER: 201287248
MAIL ADDRESS:
STREET 1: C/O KINIKSA PHARMACEUTICALS, LTD.
STREET 2: CLARENDON HOUSE, 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
FORMER NAME:
FORMER CONFORMED NAME: Mahoney Stephen
DATE OF NAME CHANGE: 20180521
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Magenta Therapeutics, Inc.
CENTRAL INDEX KEY: 0001690585
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 TECHNOLOGY SQUARE
STREET 2: 5TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-201-2700
MAIL ADDRESS:
STREET 1: 100 TECHNOLOGY SQUARE
STREET 2: 5TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-11-02
0
0001690585
Magenta Therapeutics, Inc.
MGTA
0001741389
Mahoney Stephen F.
C/O MAGENTA THERAPEUTICS, INC.
100 TECHNOLOGY SQUARE
CAMBRIDGE
MA
02139
0
1
0
0
See Remarks
Stock Option (Right to Buy)
6.28
2020-11-02
4
A
0
435000
0.00
A
2030-11-01
Common Stock
435000
435000
D
This option shall vest and become exerciseable over four years, with 25% of this option vesting on November 2, 2021, and the remainder vesting in 36 equal monthly installments thereafter.
Chief Financial and Operating Officer
/s/ Zoran Zdraveski, Attorney-in-Fact for Stephen F. Mahoney
2020-11-04